Anthropic的生物學 claims 遭遇速度限制
anthropic 在 ipo 文件中降低生物學 claims，引用缺乏物理實驗經驗。這影響生物技術投資者和人工智慧愛好者。
anthropic, a prominent ai company, has tempered its claims about revolutionizing biology and drug discovery in its recent ipo filing. despite previous statements from ceo dario amodei predicting ai could produce a thousand years of progress in biology in just five to 10 years, the filing acknowledges the company's lack of experience in physical experimentation and the lengthy, costly process of drug development. anthropic now recognizes that its ai-assisted discoveries will face significant regulatory and testing hurdles, potentially taking years to prove their safety and efficacy. this development affects biotech investors, ai enthusiasts, and the broader biotech industry.